Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Turkbey Website

Ismail Baris Turkbey, M.D.

Selected Publications

1)  Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O.
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.
Leukemia. 28: 413-6, 2014.
[Journal]
2)  Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical bacillus calmette-guerin therapy.
J Comput Assist Tomogr. 38: 274-6, 2014.
[Journal]
3)  Garvey B, Türkbey B, Truong H, Bernardo M, Periaswamy S, Choyke PL.
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
Diagn Interv Radiol. [Epub ahead of print], 2014.
[Journal]
4)  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
Diagnostic Value of Biparametric MRI as an Adjunct to PSA-based Detection of Prostate Cancer in Men without Prior Biopsies.
BJU Int. [Epub ahead of print], 2014.
[Journal]
5)  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. [Epub ahead of print], 2014.
[Journal]
6)  Turkbey B, Mena E, Shih J, Pinto PA, Merino MJ, Lindenberg ML, Bernardo M, McKinney YL, Adler S, Owenius R, Choyke PL, Kurdziel KA.
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Radiology. 270: 849-56, 2014.
[Journal]
7)  Turkbey B, Kobayashi H, Hoyt RF, Choyke PL, Nakajima T, Griffiths GL, Bernardo M, Rialon K, Fishman SJ, Sena LM.
Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model.
Lymphat Res Biol. 12: 32-6, 2014.
[Journal]
8)  Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA.
Multiparametric Magnetic Resonance Imaging of the Prostate Aids to Detect Lesion Progression.
J Comput Assist Tomogr. [Epub ahead of print], 2014.
[Journal]
9)  Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA.
Multiparametric MRI and Subsequent MR/Ultrasound Fusion-Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers.
BJU Int. [Epub ahead of print], 2014.
[Journal]
10)  Jeong W, Rapisarda A, Park SR, Kinders RJ, Chen A, Melillo G, Turkbey B, Steinberg SM, Choyke P, Doroshow JH, Kummar S.
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1a), in patients with refractory solid tumors.
Cancer Chemother. Pharmacol. 73: 343-8, 2014.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/16/2014.